Search Protocols under revision. Back New search Go to resultsDiseaseMain groupHematologic NeoplasmsSolid TumorsProtocol groupDermatologic OncologyT-Cell and NK-Cell NeoplasmsDiseaseNHL, T-Cell Type, cutaneous, Mycosis fungoidesSubgroupICD10C84.-C84.0MeSHLymphoma, T-Cell, CutaneousMycosis FungoidesSequenceAntineoplastic therapySubstanceInterferon alpha-2a pegylatedSubstanceInterferon alpha-2a pegylatedSubstanceInterferon alpha-2a pegylatedSubstanceInterferon alpha-2a pegylatedAnzahl Substanzen1 RadiotherapySupportive therapySubstanceSubstanceSubstanceSubstanceAnzahl SubstanzenProtocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentiondisease controlRisksEmetogenicityFatigueFlu-like SymptomsHepatotoxicityIncrease Aminotransferases only studiesPublicationAuthorSchiller MDiseaseKutanes T-Zell-Lymphom, Typ Mycosis fungoides, Stadium IB-III, Karnofsky >80OriginDepartment of Dermatology, University Hospital of Muenster, Muenster, GermanyProtocols in Revision 1 protocol foundPeginterferon alpha-2a 180, cutaneous T-cell Lymphoma (PID3068 V1.0)
